ACADIA Pharmaceuticals
Utility Patents

Last updated:

List of all ACADIA Pharmaceuticals patents 14 in total

Status Patent
Grant
Utility: Compounds, salts thereof and methods for treatment of diseases External link
Filling date: 12 Sep 2025 Issue date: 13 Sep 2022
Grant
Utility: Compounds, salts thereof and methods for treatment of diseases External link
Filling date: 12 Sep 2025 Issue date: 31 May 2022
Grant
Utility: Combination of pimavanserin and cytochrome P450 modulators External link
Filling date: 12 Sep 2025 Issue date: 7 Dec 2021
Grant
Utility: Manufacturing methods and polymorphs of a thiazoline anti-hyperalgesic agent External link
Filling date: 12 Sep 2025 Issue date: 2 Nov 2021
Grant
Utility: Pimavanserin for treating impulse control disorder External link
Filling date: 12 Sep 2025 Issue date: 5 Oct 2021
Grant
Utility: Compounds for pain treatment, compositions comprising same, and methods of using same External link
Filling date: 12 Sep 2025 Issue date: 17 Aug 2021
Grant
Utility: Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)ph- enylmethyl)carbamide and its tartrate salt and polymorphic form C External link
Filling date: 12 Sep 2025 Issue date: 20 Apr 2021
Grant
Utility: Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)ph- enylmethyl)carbamide and its tartrate salt and polymorphic form External link
Filling date: 12 Sep 2025 Issue date: 20 Apr 2021
Grant
Utility: Formulations of pimavanserin External link
Filling date: 12 Sep 2025 Issue date: 1 Dec 2020
Grant
Utility: Formulations of pimavanserin External link
Filling date: 12 Sep 2025 Issue date: 12 May 2020
Grant
Utility: Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)ph- enylmethyl)carbamide and its tartrate salt and polymorphic form C External link
Filling date: 12 Sep 2025 Issue date: 24 Mar 2020
Grant
Utility: Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases External link
Filling date: 12 Sep 2025 Issue date: 7 Jan 2020
Grant
Utility: Combination of pimavanserin and cytochrome P450 modulators External link
Filling date: 12 Sep 2025 Issue date: 31 Dec 2019
Grant
Utility: Formulations of pimavanserin External link
Filling date: 12 Sep 2025 Issue date: 22 Oct 2019

Showing 1 to 14 of 14 patents.